Physician profile
Chris A Magee
NPI 1346257730
$9,656.45
in general payments reported to CMS, 2019-2025
53 companies · $1,864 in 2025
The $1,864 reported for 2025 was more than what 78% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,819 · 2020: $748 · 2021: $367 · 2022: $1,328 · 2023: $1,934 · 2024: $1,596 · 2025: $1,864.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,252 · Education: $125 · Gift: $16.65.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,252.49 |
| Education | $124.87 |
| Gift | $16.65 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bayer Healthcare Pharmaceuticals INC. | $1,105.96 | 2019-2025 | |
| Astellas Pharma US INC | $1,047.20 | 2019-2025 | Xtandi, Padcev |
| Janssen Biotech, INC. | $964.64 | 2019-2025 | Erleada, Akeega, Balversa |
| Sumitomo Pharma America, INC. | $870.31 | 2023-2025 | Orgovyx, Gemtesa |
| Pfizer INC. | $697.80 | 2019-2025 | |
| Abbvie INC. | $566.72 | 2019-2025 | |
| Dendreon Pharmaceuticals LLC | $321.37 | 2019-2025 | Provenge |
| Merck Sharp & Dohme LLC | $293.60 | 2019-2025 | Keytruda, Welireg, Lynparza |
| Boston Scientific Corporation | $283.94 | 2019-2025 | Spaceoar Vue System - 10ml, Ams 700 |
| Accord Healthcare, INC. | $279.73 | 2022-2025 | |
| Genzyme Corporation | $223.04 | 2019-2023 | |
| Sun Pharmaceutical Industries INC. | $213.14 | 2019-2024 | Yonsa |
| Novartis Pharmaceuticals Corporation | $209.07 | 2019-2025 | |
| Rochester Medical Corporation | $181.97 | 2022 | |
| Tolmar Pharmaceuticals, INC. | $158.77 | 2019-2022 |
Show all 53 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Endo Pharmaceuticals INC. | $148.61 | 2019-2023 | Aveed, Xiaflex |
| Astrazeneca Pharmaceuticals LP | $144.53 | 2021-2025 | Lynparza |
| Tolmar, INC. | $141.01 | 2023-2025 | Jatenzo, Eligard |
| Antares Pharma, INC. | $120.73 | 2019-2023 | Nocdurna, Tlando, Xyosted |
| Allergan, INC. | $120.67 | 2019-2020 | |
| Hollister Incorporated | $113.61 | 2022-2023 | Infyna Chic, Vapro |
| Medtronic, INC. | $103.44 | 2023-2025 | Interstim, Altaviva |
| Myovant Sciences INC. | $99.71 | 2021-2022 | |
| Myriad Genetic Laboratories, INC. | $96.98 | 2021-2025 | Prolaris |
| Progenics Pharmaceuticals, INC. | $83.36 | 2023-2024 | Pylarify |
| Axonics, INC. | $77.35 | 2022-2024 | Axonics |
| Coloplast Corp | $75.61 | 2023-2025 | Speedicath |
| Ferring Pharmaceuticals INC. | $75.57 | 2019-2024 | Adstiladrin |
| Amgen INC. | $74.20 | 2019 | |
| Urogen Pharma, INC. | $67.25 | 2021-2024 | Jelmyto |
| Aytu Biopharma, INC. | $64.05 | 2019 | |
| Vertex Pharmaceuticals Incorporated | $60.60 | 2024-2025 | |
| Blue Earth Diagnostics | $53.93 | 2019 | |
| Urovant Sciences INC | $53.70 | 2021-2022 | |
| Zyla Life Sciences, INC. | $52.70 | 2019 | |
| Telix Pharmaceuticals | $44.74 | 2023-2024 | Illuccix |
| Immunitybio, INC. | $34.36 | 2025 | |
| Endo USA, INC. | $33.77 | 2025 | Xiaflex, Aveed |
| Olympus America INC. | $32.21 | 2025 | Itind System |
| Hospira, INC. | $31.05 | 2019 | |
| Organon LLC | $25.97 | 2025 | |
| Clinigen, INC. | $23.77 | 2019 | |
| Mission Pharmacal Company | $22.79 | 2020 | |
| Verity Pharmaceuticals INC. | $19.27 | 2023 | Trelstar |
| Edap Technomed INC | $18.88 | 2025 | |
| Neotract INC. | $18.52 | 2019 | |
| 180 Medical, INC. | $18.48 | 2023 | |
| Foundation Medicine, INC. | $17.89 | 2020 | |
| Medline Industries LP | $17.17 | 2025 | |
| Argon Medical Devices, INC. | $15.77 | 2025 | Clot Management |
| Alexion Pharmaceuticals, INC. | $13.50 | 2019 | |
| Clarus Therapeutics INC. | $11.85 | 2021 | |
| Medtronic USA, INC. | $11.59 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Chris Magee listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.